Junlan Yang
Beijing Key Lab For Source Control Technology Of Water Pollution
Beijing, 100083, China
Beijing, 100083, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
A source-oriented precise risk assessment of trace metal(loid)s in sediments of the Yangtze River Basin.
Journal: Environmental pollution (Barking, Essex : 1987)
Published: April 15, 2025
A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer.
Journal: Future oncology (London, England)
Published: December 04, 2024
Rapid urbanization decelerates regional net anthropogenic phosphorus input: Evidence from the Chengdu-Chongqing urban agglomeration in China.
Journal: Journal of environmental management
Published: November 27, 2024
Dynamic characteristics of net anthropogenic phosphorus input to the upper Yangtze River Basin from 1989 to 2019: Focus on the phosphate ore rich area in China.
Journal: Journal of environmental management
Published: April 19, 2023
Organising pneumonia caused by hormone (tamoxifen) therapy after radiotherapy for breast cancer: a case report and review of the literature.
Journal: Annals of translational medicine
Published: October 24, 2022
Efficacy and safety of inetetamab in combination with chemotherapy as first-line treatment of HER2-positive metastatic breast cancer: a subgroup analysis in the HOPES study.
Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: December 28, 2021
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer.
Journal: Therapeutic advances in medical oncology
Published: December 21, 2021
Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: June 23, 2021
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
Journal: Cancer
Published: September 01, 2019
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial.
Journal: The Lancet. Oncology
Published: October 05, 2016
GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 01, 2016
Last Updated: 09/26/2026